Uli Christian BROEDL,Maximilian von EYNATTEN,Odd-Erik JOHANSEN,Thomas KLEIN,Gerd Roland LUIPPOLD
申请号：
US16695324
公开号：
US20200268777A1
申请日:
2019.11.26
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to the treatment or prevention of renal impairment and/or complications using a SGLT-2 inhibitor, for example in patients diagnosed with metabolic disorders and related conditions.
